Liraglutide

Product NDC
70377-094
11-digit product format
703770094
Labeler code
70377
Product ID
70377-094_be87d32a-f1c2-bdd7-6bf8-30dff2d26cc4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
liraglutide
Dosage form
INJECTION
Route
SUBCUTANEOUS
Labeler
Biocon Pharma Inc.
Application
ANDA215245
Marketing category
ANDA
Marketing start
2026-04-25
Substance
LIRAGLUTIDE
Active strength
6 mg/mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215245-001LIRAGLUTIDELIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12026-03-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A215245-001AP1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A215245-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12026-03-11caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215245-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12026-03-11a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A215245-001AP11caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215245-001AP11a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Liraglutide
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LIRAGLUTIDE6 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
839I73S42AInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
897122Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
cb032379-043b-443c-d552-b5d25f27f3c4Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d8dac6c8-0045-42cf-b357-c3350b4ada5cProduct name220251021
0dd952e2-ff48-4739-9b8d-72ae0b326834Product name220200323
ce962b7e-f9f8-43e6-8d30-41514e79f3e4Product name120190201
2f360a13-6ea8-4c2b-b2ef-10133c2836d9Product name120150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70377-094-52Liraglutide2 in 1 CARTONINJECTION212
70377-094-52Liraglutide3 mL in 1 SYRINGE, PLASTICINJECTION312
70377-094-53Liraglutide3 mL in 1 SYRINGE, PLASTICINJECTION312
70377-094-53Liraglutide3 in 1 CARTONINJECTION312

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LiraglutideLIRAGLUTIDEBiocon Pharma Inc.cb032379-043b-443c-d552-b5d25f27f3c42025-10-10Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215245
application number: ANDA215245
ndc (product): 70377-094

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
897122liraglutide 6 MG/ML in 3 ML Pen InjectorPSNcb032379-043b-443c-d552-b5d25f27f3c412
8971223 ML liraglutide 6 MG/ML Pen InjectorSCDcb032379-043b-443c-d552-b5d25f27f3c412
897122liraglutide 18 MG per 3 ML Pen InjectorSYcb032379-043b-443c-d552-b5d25f27f3c412

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70377-094-52703770094522 SYRINGE, PLASTIC in 1 CARTON (70377-094-52) / 3 mL in 1 SYRINGE, PLASTIC2026-04-25NoNoCurrent
70377-094-53703770094533 SYRINGE, PLASTIC in 1 CARTON (70377-094-53) / 3 mL in 1 SYRINGE, PLASTIC2026-04-25NoNoCurrent